Boundless Bio, Inc.
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.59% | 14.76% | 10.96% | -1.15% | -11.55% |
| Total Depreciation and Amortization | 81.04% | 6.84% | 15.19% | 19.58% | 18.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 136.81% | 14.62% | 33.42% | 82.01% | 155.85% |
| Change in Net Operating Assets | -910.34% | 180.33% | 306.32% | 305.60% | 170.65% |
| Cash from Operations | -1.92% | 20.96% | 23.31% | 8.51% | 1.25% |
| Capital Expenditure | 54.07% | 80.29% | 78.47% | 74.85% | 47.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.48% | 228.85% | 262.73% | 378.71% | 198.52% |
| Cash from Investing | 59.52% | 219.79% | 244.83% | 320.05% | 191.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.83% | -99.85% | -99.85% | -99.75% | -99.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 99.74% |
| Cash from Financing | -55.30% | -99.84% | -99.84% | -99.74% | -99.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.74% | 123.60% | -402.64% | -231.09% | -67.43% |